Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-26T07:08:30.956Z Has data issue: false hasContentIssue false

Pentastarch resuscitation in severe sepsis and septic shock

Published online by Cambridge University Press:  21 May 2015

Robert S. Green*
Affiliation:
Departments of Medicine (Division of Critical Care Medicine) and Emergency Medicine, Dalhousie University, Halifax, NS
Peter J. Zed
Affiliation:
Departments of Emergency Medicine and Pharmacy, Queen Elizabeth II Health Sciences Centre, Halifax, NS
Lauralyn McIntyre
Affiliation:
Department of Medicine (Division of Critical Care), Ottawa Health Research Institute Centre for Transfusion and Critical Care Research, Ottawa Hospital, Ottawa, Ont.
*
Department of Medicine (Division of Critical Care Medicine), Department of Emergency Medicine, Rm. 377 Bethune Building, 1278 Tower Rd., Halifax NS B3H 2Y9; [email protected]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Knowledge to Practice • Des connaissances à la pratique
Copyright
Copyright © Canadian Association of Emergency Physicians 2010

References

REFERENCES

1. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. Cochrane Injuries Group Albumin Reviewers. BMJ 1998;317:235–40.Google Scholar
2. Alderson, P, Bunn, F, Lefebvre, C, et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev. 2004;(4):CD001208.Google Scholar
3. Finfer, S, Bellomo, R, Boyce, N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350:2247–56.Google Scholar
4. McIntyre, LA, Fergusson, D, Cook, DJ, et al. Resuscitating patients with early severe sepsis: a Canadian multicentre observational study. Can J Anaesth 2007;54:790–8.10.1007/BF03021706Google Scholar
5. Vincent, JL, Moreno, R, Takala, J, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ/dysfunction/failure. On behalf of the Working Group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707–10.10.1007/BF01709751Google Scholar
6. Strehlow, MC, Emond, SD, Shapiro, NI, et al. National study of emergency department visits for sepsis, 1992 to 2001. Ann Emerg Med. 2006;48:326–31.10.1016/j.annemergmed.2006.05.003Google Scholar
7. Martin, GS, Mannino, DM, Eaton, S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546–54.10.1056/NEJMoa022139Google Scholar
8. Angus, DC, Linde-Zwirble, WT, Lidicker, J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303–10.10.1097/00003246-200107000-00002Google Scholar
9. Green, RS, Djogovic, D, Gray, S, et al. Canadian Association of Emergency Physicians Sepsis Guidelines: the optimal management of severe sepsis in Canadian emergency departments. CJEM 2008;10:443–59.10.1017/S148180350001054XGoogle Scholar
10. Dellinger, RP, Levy, MM, Carlet, JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296327.10.1097/01.CCM.0000298158.12101.41Google Scholar
11. Green, RS, Hall, RI. Con: starches are not preferable to albumin during cardiac surgery: a contrary opinion. J Cardiothorac Vasc Anesth 2008;22:485–91.10.1053/j.jvca.2008.03.002Google Scholar
12. Traylor, RJ, Pearl, RG. Crystalloid versus colloid versus colloid: all colloids are not created equal. Anesth Analg 1996;83:209–12.10.1213/00000539-199608000-00001Google Scholar
13. Imm, A, Carlson, RW. Fluid resuscitation in circulatory shock. Crit Care Clin 1993;9:313–33.10.1016/S0749-0704(18)30198-2Google Scholar
14. Ross, AD, Angaran, DM. Colloids vs. crystalloids — a continuing controversy. Drug Intell Clin Pharm 1984;18:202–12.Google Scholar
15. Vincent, JL, Navickis, RJ, Wilkes, MM. Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med 2004;32:20292038.10.1097/01.CCM.0000142574.00425.E9Google Scholar
16. Wilkes, MM, Navickis, RJ. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001;135:149–64.10.7326/0003-4819-135-3-200108070-00007Google Scholar
17. Haynes, GR, Navickis, RJ, Wilkes, MM. Albumin administration — what is the evidence of clinical benefit? A systematic review of randomized controlled trials. Eur J Anaesthesiol 2003;20:771–93.10.1097/00003643-200310000-00003Google Scholar
18. Choi, PT, Yip, G, Quinonez, LG, et al. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 1999;27:200–10.10.1097/00003246-199901000-00053Google Scholar
19. Dieterich, HJ. Recent developments in European colloid solutions. J Trauma 2003;54(Suppl):S26–30.Google Scholar
20. Schortgen, F, Deye, N, Brochard, L. Preferred plasma volume expanders for critically ill patients: results of an international survey. Intensive Care Med 2004;30:2222–9.10.1007/s00134-004-2415-1Google Scholar
21. Boldt, J. Volume therapy in cardiac surgery: Are Americans different from Europeans? J Cardiothorac Vasc Anesth 2006;20:98105.10.1053/j.jvca.2005.07.023Google Scholar
22. Schortgen, F, Lacherade, JC, Bruneel, F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001;357:911–6.10.1016/S0140-6736(00)04211-2Google Scholar
23. The NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283–97.10.1056/NEJMoa0810625Google Scholar